172 related articles for article (PubMed ID: 11817708)
21. Risk factors and long-term follow-up of adrenal incidentalomas.
Barzon L; Scaroni C; Sonino N; Fallo F; Paoletta A; Boscaro M
J Clin Endocrinol Metab; 1999 Feb; 84(2):520-6. PubMed ID: 10022410
[TBL] [Abstract][Full Text] [Related]
22. Cushing's syndrome due to bilateral adrenocortical adenomas with unique histological features.
Nomura K; Saito H; Aiba M; Iihara M; Obara T; Takano K
Endocr J; 2003 Apr; 50(2):155-62. PubMed ID: 12803235
[TBL] [Abstract][Full Text] [Related]
23. A patient with preclinical Cushing's syndrome and excessive DHEA-S secretion having unilateral adrenal carcinoma and contralateral adenoma.
Midorikawa S; Hashimoto S; Kuriki M; Katoh K; Watanabe T; Sasano H; Nishikawa T
Endocr J; 1999 Feb; 46(1):59-66. PubMed ID: 10426568
[TBL] [Abstract][Full Text] [Related]
24. 17-Hydroxyprogesterone response to ACTH in bilateral and monolateral adrenal incidentalomas.
Bernini GP; Brogi G; Vivaldi MS; Argenio GF; Sgrò M; Moretti A; Salvetti A
J Endocrinol Invest; 1996 Dec; 19(11):745-52. PubMed ID: 9061508
[TBL] [Abstract][Full Text] [Related]
25. Preclinical Cushing's syndrome in adrenal "incidentalomas": comparison with adrenal Cushing's syndrome.
Reincke M; Nieke J; Krestin GP; Saeger W; Allolio B; Winkelmann W
J Clin Endocrinol Metab; 1992 Sep; 75(3):826-32. PubMed ID: 1517373
[TBL] [Abstract][Full Text] [Related]
26. Black (or brown) adrenal cortical adenoma: its characteristic features on computed tomography and endocrine data.
Komiya I; Takasu N; Aizawa T; Yamada T; Koizumi Y; Hashizume K; Ishihara M; Hiramatsu K; Ichikawa K; Katakura M
J Clin Endocrinol Metab; 1985 Oct; 61(4):711-7. PubMed ID: 4031014
[TBL] [Abstract][Full Text] [Related]
27. [Role of adrenocortical scintigraphy in the exploration of incidentally discovered tumors].
Delemer B; Gibold C; Caron J; Liehn JC; Delisle MJ
Ann Endocrinol (Paris); 1992; 53(4):147-52. PubMed ID: 1339063
[TBL] [Abstract][Full Text] [Related]
28. Aberrant adrenal sensitivity to multiple ligands in unilateral incidentaloma with subclinical autonomous cortisol hypersecretion: a prospective clinical study.
Reznik Y; Lefebvre H; Rohmer V; Charbonnel B; Tabarin A; Rodien P; Lecomte P; Bardet S; Coffin C; Mahoudeau J;
Clin Endocrinol (Oxf); 2004 Sep; 61(3):311-9. PubMed ID: 15355446
[TBL] [Abstract][Full Text] [Related]
29. Plasma dehydroepiandrosterone sulfate levels in patients with hyperfunctioning and non-hyperfunctioning adrenal tumors before and after adrenal surgery.
Tóth M; Rácz K; Varga I; Adleff V; Jakab C; Fútó L; Kiss R; Gláz E
Eur J Endocrinol; 1997 Mar; 136(3):290-5. PubMed ID: 9100554
[TBL] [Abstract][Full Text] [Related]
30. Twenty-four hour 17-hydroxyprogesterone response to adrenocorticotropine in adrenal incidentalomas: augmented response after adrenalectomy in two patients.
Kamel N; Erdoğan MF; Tonyukuk V; Ilgin SD; Erdoğan G
Endocr J; 2002 Feb; 49(1):35-40. PubMed ID: 12008748
[TBL] [Abstract][Full Text] [Related]
31. Low basal androstenedione levels plus augmented 17alpha-hydroxyprogesterone and low dehydroepiandrosterone sulfate responses to adrenocorticotropic hormone stimulation in patients with adrenal incidentaloma.
Ozgen AG; Bayraktar F; Yilmaz C
Endocr Pract; 2001; 7(6):448-53. PubMed ID: 11747281
[TBL] [Abstract][Full Text] [Related]
32. Alterations in hypothalamic-pituitary-adrenal function immediately after resection of adrenal adenomas in patients with Cushing's syndrome and others with incidentalomas and subclinical hypercortisolism.
Khawandanah D; ElAsmar N; Arafah BM
Endocrine; 2019 Jan; 63(1):140-148. PubMed ID: 30259310
[TBL] [Abstract][Full Text] [Related]
33. Endocrine evaluation of incidentally discovered adrenal masses (incidentalomas).
Osella G; Terzolo M; Borretta G; Magro G; Alí A; Piovesan A; Paccotti P; Angeli A
J Clin Endocrinol Metab; 1994 Dec; 79(6):1532-9. PubMed ID: 7989452
[TBL] [Abstract][Full Text] [Related]
34. Biochemical screening for subclinical cortisol-secreting adenomas amongst adrenal incidentalomas.
Valli N; Catargi B; Ronci N; Vergnot V; Leccia F; Ferriere JM; Chene G; Grenier N; Laurent F; Tabarin A
Eur J Endocrinol; 2001 Apr; 144(4):401-8. PubMed ID: 11275951
[TBL] [Abstract][Full Text] [Related]
35. Benign cortisol-secreting adrenocortical adenomas produce small amounts of androgens.
Kamenicky P; Houdoin L; Ferlicot S; Salenave S; Brailly S; Droupy S; Meduri G; Sasano H; Suzuki T; Young J; Chanson P
Clin Endocrinol (Oxf); 2007 Jun; 66(6):778-88. PubMed ID: 17408424
[TBL] [Abstract][Full Text] [Related]
36. Characteristics of recovery of adrenocortical function after treatment for Cushing's syndrome due to pituitary or adrenal adenomas.
Klose M; Jørgensen K; Kristensen LØ
Clin Endocrinol (Oxf); 2004 Sep; 61(3):394-9. PubMed ID: 15355458
[TBL] [Abstract][Full Text] [Related]
37. Comparative analysis of plasma 17-hydroxyprogesterone and cortisol responses to ACTH in patients with various adrenal tumors before and after unilateral adrenalectomy.
Tóth M; Rácz K; Adleff V; Varga I; Fütö L; Jakab C; Karlinger K; Kiss R; Gláz E
J Endocrinol Invest; 2000 May; 23(5):287-94. PubMed ID: 10882146
[TBL] [Abstract][Full Text] [Related]
38. Analysis of cortisol secretion in hormonally inactive adrenocortical incidentalomas: study of in vitro steroid secretion and immunohistochemical localization of steroidogenic enzymes.
Midorikawa S; Sanada H; Hashimoto S; Suzuki T; Watanabe T; Sasano H
Endocr J; 2001 Apr; 48(2):167-74. PubMed ID: 11456263
[TBL] [Abstract][Full Text] [Related]
39. The prevalence of 21-hydroxylase deficiency in adrenal incidentalomas - hormonal and mutation screening.
Wagnerova H; Lazúrová I; Habalová V; Dudásová D; Vrzgula A
Exp Clin Endocrinol Diabetes; 2008 May; 116(5):272-5. PubMed ID: 18589890
[TBL] [Abstract][Full Text] [Related]
40. The improvement of insulin resistance in patients with adrenal incidentaloma by surgical resection.
Midorikawa S; Sanada H; Hashimoto S; Suzuki T; Watanabe T
Clin Endocrinol (Oxf); 2001 Jun; 54(6):797-804. PubMed ID: 11422115
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
